41 | 0.53 | 26 | 1.0 | 0.0000025 | cfa04146=Peroxisome |
39 | 0.53 | 25 | 1.0 | 0.0000038 | cfa04640=Hematopoietic cell lineage |
29 | 0.59 | 13 | 1.0 | 0.0000044 | cfa00980=Metabolism of xenobiotics by cytochrome P450 |
22 | 0.63 | 10 | 1.0 | 0.000016 | cfa00140=Steroid hormone biosynthesis |
28 | 0.56 | 19 | 1.0 | 0.000027 | cfa05204=Chemical carcinogenesis |
11 | 0.85 | 3 | 1.0 | 0.000033 | cfa00511=Other glycan degradation |
25 | 0.57 | 16 | 1.0 | 0.000052 | cfa00600=Sphingolipid metabolism |
9 | 0.90 | 2 | 1.0 | 0.000074 | cfa00740=Riboflavin metabolism |
23 | 0.58 | 14 | 1.0 | 0.000079 | cfa00380=Tryptophan metabolism |
15 | 0.68 | 6 | 1.0 | 0.000096 | cfa04977=Vitamin digestion and absorption |
22 | 0.56 | 17 | 1.0 | 0.00017 | cfa00071=Fatty acid metabolism |
22 | 0.56 | 17 | 1.0 | 0.00017 | cfa05150=Staphylococcus aureus infection |
26 | 0.53 | 27 | 1.0 | 0.00017 | cfa00982=Drug metabolism - cytochrome P450 |
49 | 0.44 | 42 | 1.0 | 0.00018 | cfa04142=Lysosome |
56 | 0.42 | 47 | 1.0 | 0.00024 | cfa04630=Jak-STAT signaling pathway |
34 | 0.48 | 35 | 1.0 | 0.00026 | cfa03320=PPAR signaling pathway |
13 | 0.68 | 5 | 1.0 | 0.00027 | cfa00531=Glycosaminoglycan degradation |
20 | 0.56 | 21 | 1.0 | 0.00043 | cfa04975=Fat digestion and absorption |
22 | 0.54 | 24 | 1.0 | 0.00043 | cfa00830=Retinol metabolism |
19 | 0.56 | 20 | 1.0 | 0.00053 | cfa00565=Ether lipid metabolism |
14 | 0.61 | 11 | 1.0 | 0.00092 | cfa00591=Linoleic acid metabolism |
20 | 0.53 | 28 | 1.0 | 0.0011 | cfa02010=ABC transporters |
22 | 0.50 | 32 | 1.0 | 0.0015 | cfa00280=Valine, leucine and isoleucine degradation |
33 | 0.44 | 44 | 1.0 | 0.0020 | cfa04974=Protein digestion and absorption |
15 | 0.56 | 21 | 1.0 | 0.0022 | cfa03440=Homologous recombination |
14 | 0.56 | 19 | 1.0 | 0.0028 | cfa00650=Butanoate metabolism |
35 | 0.42 | 48 | 1.0 | 0.0035 | cfa05323=Rheumatoid arthritis |
16 | 0.52 | 31 | 1.0 | 0.0043 | cfa00350=Tyrosine metabolism |
16 | 0.52 | 31 | 1.0 | 0.0043 | cfa05320=Autoimmune thyroid disease |
12 | 0.57 | 15 | 1.0 | 0.0044 | cfa00592=alpha-Linolenic acid metabolism |
15 | 0.52 | 30 | 1.0 | 0.0054 | cfa00760=Nicotinate and nicotinamide metabolism |
21 | 0.47 | 39 | 1.0 | 0.0054 | cfa05144=Malaria |
84 | 0.36 | 66 | 1.0 | 0.0059 | cfa04080=Neuroactive ligand-receptor interaction |
16 | 0.48 | 33 | 1.0 | 0.0091 | cfa05143=African trypanosomiasis |
12 | 0.52 | 29 | 1.0 | 0.011 | cfa00340=Histidine metabolism |
14 | 0.48 | 34 | 0.99 | 0.015 | cfa05330=Allograft rejection |
9 | 0.56 | 18 | 1.0 | 0.015 | cfa04614=Renin-angiotensin system |
3 | 1.0 | 1 | 1.0 | 0.021 | cfa00780=Biotin metabolism |
35 | 0.38 | 56 | 0.99 | 0.021 | cfa00240=Pyrimidine metabolism |
15 | 0.44 | 43 | 0.99 | 0.030 | cfa04940=Type I diabetes mellitus |
11 | 0.48 | 36 | 0.99 | 0.032 | cfa00563=Glycosylphosphatidylinositol(GPI)-anchor biosynthesis |
29 | 0.38 | 54 | 0.98 | 0.032 | cfa04512=ECM-receptor interaction |
20 | 0.41 | 50 | 0.98 | 0.034 | cfa04622=RIG-I-like receptor signaling pathway |
9 | 0.50 | 32 | 0.99 | 0.037 | cfa00100=Steroid biosynthesis |
10 | 0.48 | 37 | 0.99 | 0.042 | cfa04950=Maturity onset diabetes of the young |
7 | 0.54 | 23 | 0.99 | 0.042 | cfa03450=Non-homologous end-joining |
6 | 0.55 | 22 | 0.99 | 0.055 | cfa00430=Taurine and hypotaurine metabolism |
6 | 0.55 | 22 | 0.99 | 0.055 | cfa00790=Folate biosynthesis |
22 | 0.38 | 58 | 0.97 | 0.060 | cfa05140=Leishmaniasis |
12 | 0.43 | 46 | 0.97 | 0.062 | cfa00512=Mucin type O-Glycan biosynthesis |
3 | 0.75 | 4 | 0.99 | 0.068 | cfa00061=Fatty acid biosynthesis |
3 | 0.75 | 4 | 0.99 | 0.068 | cfa00232=Caffeine metabolism |
23 | 0.37 | 62 | 0.96 | 0.070 | cfa04115=p53 signaling pathway |
29 | 0.36 | 64 | 0.96 | 0.071 | cfa00564=Glycerophospholipid metabolism |
8 | 0.47 | 38 | 0.98 | 0.071 | cfa00120=Primary bile acid biosynthesis |
20 | 0.38 | 59 | 0.96 | 0.074 | cfa00561=Glycerolipid metabolism |
19 | 0.38 | 57 | 0.96 | 0.076 | cfa04612=Antigen processing and presentation |
48 | 0.34 | 74 | 0.95 | 0.076 | cfa05152=Tuberculosis |
18 | 0.38 | 53 | 0.96 | 0.077 | cfa00510=N-Glycan biosynthesis |
2 | 1.0 | 1 | 1.0 | 0.077 | cfa00290=Valine, leucine and isoleucine biosynthesis |
16 | 0.39 | 52 | 0.96 | 0.079 | cfa00500=Starch and sucrose metabolism |
16 | 0.39 | 52 | 0.96 | 0.079 | cfa04621=NOD-like receptor signaling pathway |
12 | 0.41 | 49 | 0.96 | 0.080 | cfa00410=beta-Alanine metabolism |
7 | 0.47 | 39 | 0.97 | 0.093 | cfa00604=Glycosphingolipid biosynthesis - ganglio series |
33 | 0.34 | 72 | 0.94 | 0.094 | cfa05146=Amoebiasis |
8 | 0.44 | 41 | 0.96 | 0.097 | cfa00900=Terpenoid backbone biosynthesis |
4 | 0.57 | 15 | 0.98 | 0.099 | cfa00460=Cyanoamino acid metabolism |
4 | 0.57 | 15 | 0.98 | 0.099 | cfa00750=Vitamin B6 metabolism |
12 | 0.40 | 51 | 0.95 | 0.10 | cfa00052=Galactose metabolism |
12 | 0.40 | 51 | 0.95 | 0.10 | cfa00983=Drug metabolism - other enzymes |
9 | 0.43 | 46 | 0.96 | 0.10 | cfa00040=Pentose and glucuronate interconversions |
5 | 0.50 | 32 | 0.97 | 0.11 | cfa04122=Sulfur relay system |
26 | 0.35 | 70 | 0.93 | 0.12 | cfa04064=NF-kappa B signaling pathway |
10 | 0.40 | 51 | 0.94 | 0.13 | cfa05332=Graft-versus-host disease |
17 | 0.36 | 63 | 0.92 | 0.13 | cfa00480=Glutathione metabolism |
21 | 0.35 | 68 | 0.92 | 0.13 | cfa05133=Pertussis |
7 | 0.44 | 45 | 0.95 | 0.13 | cfa00770=Pantothenate and CoA biosynthesis |
12 | 0.38 | 61 | 0.92 | 0.15 | cfa03410=Base excision repair |
21 | 0.34 | 71 | 0.90 | 0.15 | cfa04976=Bile secretion |
15 | 0.36 | 65 | 0.90 | 0.16 | cfa04978=Mineral absorption |
4 | 0.50 | 32 | 0.96 | 0.16 | cfa00072=Synthesis and degradation of ketone bodies |
50 | 0.32 | 78 | 0.88 | 0.16 | cfa00230=Purine metabolism |
8 | 0.40 | 51 | 0.93 | 0.16 | cfa05310=Asthma |
6 | 0.43 | 46 | 0.94 | 0.17 | cfa00603=Glycosphingolipid biosynthesis - globo series |
2 | 0.67 | 8 | 0.98 | 0.19 | cfa00785=Lipoic acid metabolism |
8 | 0.38 | 55 | 0.90 | 0.20 | cfa00062=Fatty acid elongation |
8 | 0.38 | 55 | 0.90 | 0.20 | cfa03430=Mismatch repair |
11 | 0.35 | 67 | 0.88 | 0.22 | cfa05340=Primary immunodeficiency |
12 | 0.34 | 73 | 0.85 | 0.25 | cfa00260=Glycine, serine and threonine metabolism |
40 | 0.31 | 81 | 0.81 | 0.25 | cfa04145=Phagosome |
42 | 0.31 | 82 | 0.80 | 0.25 | cfa05164=Influenza A |
13 | 0.33 | 75 | 0.83 | 0.27 | cfa00970=Aminoacyl-tRNA biosynthesis |
1 | 1.0 | 1 | 1.0 | 0.28 | cfa00472=D-Arginine and D-ornithine metabolism |
4 | 0.40 | 51 | 0.89 | 0.29 | cfa00130=Ubiquinone and other terpenoid-quinone biosynthesis |
4 | 0.40 | 51 | 0.89 | 0.29 | cfa00920=Sulfur metabolism |
8 | 0.35 | 69 | 0.84 | 0.29 | cfa00630=Glyoxylate and dicarboxylate metabolism |
36 | 0.30 | 85 | 0.76 | 0.30 | cfa04514=Cell adhesion molecules (CAMs) |
10 | 0.33 | 75 | 0.81 | 0.31 | cfa00640=Propanoate metabolism |
2 | 0.50 | 32 | 0.93 | 0.31 | cfa00730=Thiamine metabolism |
7 | 0.35 | 68 | 0.84 | 0.31 | cfa01040=Biosynthesis of unsaturated fatty acids |
14 | 0.32 | 77 | 0.78 | 0.32 | cfa05134=Legionellosis |
44 | 0.30 | 86 | 0.74 | 0.32 | cfa05168=Herpes simplex infection |
11 | 0.32 | 76 | 0.79 | 0.33 | cfa00860=Porphyrin and chlorophyll metabolism |
12 | 0.32 | 79 | 0.77 | 0.36 | cfa00620=Pyruvate metabolism |
31 | 0.30 | 87 | 0.70 | 0.38 | cfa05145=Toxoplasmosis |
6 | 0.33 | 75 | 0.79 | 0.38 | cfa00670=One carbon pool by folate |
12 | 0.31 | 81 | 0.73 | 0.39 | cfa04672=Intestinal immune network for IgA production |
12 | 0.31 | 81 | 0.73 | 0.39 | cfa04973=Carbohydrate digestion and absorption |
14 | 0.30 | 84 | 0.72 | 0.40 | cfa00520=Amino sugar and nucleotide sugar metabolism |
11 | 0.31 | 83 | 0.72 | 0.41 | cfa05219=Bladder cancer |
23 | 0.29 | 88 | 0.69 | 0.41 | cfa05222=Small cell lung cancer |
8 | 0.31 | 81 | 0.72 | 0.44 | cfa00601=Glycosphingolipid biosynthesis - lacto and neolacto series |
8 | 0.31 | 81 | 0.72 | 0.44 | cfa04966=Collecting duct acid secretion |
5 | 0.31 | 80 | 0.73 | 0.47 | cfa00533=Glycosaminoglycan biosynthesis - keratan sulfate |
1 | 0.50 | 32 | 0.92 | 0.48 | cfa00300=Lysine biosynthesis |
10 | 0.29 | 89 | 0.67 | 0.48 | cfa03030=DNA replication |
12 | 0.29 | 90 | 0.62 | 0.51 | cfa04930=Type II diabetes mellitus |
33 | 0.28 | 92 | 0.57 | 0.51 | cfa04110=Cell cycle |
16 | 0.28 | 91 | 0.59 | 0.53 | cfa05416=Viral myocarditis |
2 | 0.33 | 75 | 0.79 | 0.53 | cfa00400=Phenylalanine, tyrosine and tryptophan biosynthesis |
24 | 0.28 | 93 | 0.57 | 0.53 | cfa04972=Pancreatic secretion |
5 | 0.29 | 89 | 0.68 | 0.53 | cfa00360=Phenylalanine metabolism |
13 | 0.27 | 94 | 0.53 | 0.59 | cfa00310=Lysine degradation |
8 | 0.27 | 95 | 0.54 | 0.62 | cfa00250=Alanine, aspartate and glutamate metabolism |
8 | 0.27 | 95 | 0.54 | 0.62 | cfa00514=Other types of O-glycan biosynthesis |
4 | 0.27 | 95 | 0.59 | 0.63 | cfa00450=Selenocompound metabolism |
4 | 0.27 | 95 | 0.59 | 0.63 | cfa01210=2-Oxocarboxylic acid metabolism |
11 | 0.26 | 97 | 0.49 | 0.64 | cfa04330=Notch signaling pathway |
14 | 0.26 | 96 | 0.49 | 0.64 | cfa00330=Arginine and proline metabolism |
4 | 0.25 | 100 | 0.53 | 0.69 | cfa00053=Ascorbate and aldarate metabolism |
8 | 0.25 | 100 | 0.45 | 0.70 | cfa00270=Cysteine and methionine metabolism |
9 | 0.25 | 100 | 0.44 | 0.70 | cfa04623=Cytosolic DNA-sensing pathway |
18 | 0.25 | 98 | 0.39 | 0.71 | cfa04210=Apoptosis |
5 | 0.24 | 107 | 0.45 | 0.73 | cfa04140=Regulation of autophagy |
14 | 0.24 | 104 | 0.33 | 0.77 | cfa00010=Glycolysis / Gluconeogenesis |
7 | 0.23 | 111 | 0.38 | 0.77 | cfa05020=Prion diseases |
8 | 0.24 | 109 | 0.37 | 0.77 | cfa00051=Fructose and mannose metabolism |
28 | 0.25 | 101 | 0.28 | 0.79 | cfa04380=Osteoclast differentiation |
1 | 0.20 | 129 | 0.58 | 0.80 | cfa00524=Butirosin and neomycin biosynthesis |
6 | 0.22 | 116 | 0.35 | 0.80 | cfa05216=Thyroid cancer |
31 | 0.25 | 102 | 0.25 | 0.81 | cfa05012=Parkinson's disease |
15 | 0.23 | 110 | 0.27 | 0.82 | cfa04920=Adipocytokine signaling pathway |
16 | 0.24 | 109 | 0.27 | 0.82 | cfa04350=TGF-beta signaling pathway |
23 | 0.24 | 105 | 0.24 | 0.82 | cfa05142=Chagas disease (American trypanosomiasis) |
9 | 0.22 | 114 | 0.29 | 0.82 | cfa03420=Nucleotide excision repair |
17 | 0.23 | 112 | 0.24 | 0.83 | cfa05410=Hypertrophic cardiomyopathy (HCM) |
35 | 0.24 | 103 | 0.22 | 0.83 | cfa05202=Transcriptional misregulation in cancer |
10 | 0.22 | 116 | 0.26 | 0.84 | cfa05014=Amyotrophic lateral sclerosis (ALS) |
13 | 0.22 | 115 | 0.23 | 0.85 | cfa04370=VEGF signaling pathway |
26 | 0.24 | 108 | 0.20 | 0.86 | cfa05160=Hepatitis C |
31 | 0.24 | 106 | 0.19 | 0.86 | cfa00190=Oxidative phosphorylation |
76 | 0.25 | 99 | 0.17 | 0.86 | cfa04151=PI3K-Akt signaling pathway |
7 | 0.21 | 127 | 0.24 | 0.87 | cfa04742=Taste transduction |
15 | 0.22 | 118 | 0.18 | 0.88 | cfa05218=Melanoma |
14 | 0.22 | 122 | 0.17 | 0.90 | cfa05412=Arrhythmogenic right ventricular cardiomyopathy (ARVC) |
17 | 0.22 | 120 | 0.15 | 0.90 | cfa05414=Dilated cardiomyopathy |
4 | 0.18 | 140 | 0.23 | 0.90 | cfa00534=Glycosaminoglycan biosynthesis - heparan sulfate / heparin |
5 | 0.19 | 136 | 0.20 | 0.90 | cfa00030=Pentose phosphate pathway |
21 | 0.22 | 117 | 0.13 | 0.91 | cfa04726=Serotonergic synapse |
15 | 0.21 | 124 | 0.13 | 0.92 | cfa03008=Ribosome biogenesis in eukaryotes |
4 | 0.17 | 145 | 0.19 | 0.92 | cfa04320=Dorso-ventral axis formation |
7 | 0.19 | 134 | 0.16 | 0.92 | cfa04960=Aldosterone-regulated sodium reabsorption |
22 | 0.22 | 121 | 0.10 | 0.93 | cfa04066=HIF-1 signaling pathway |
24 | 0.22 | 119 | 0.11 | 0.93 | cfa04670=Leukocyte transendothelial migration |
28 | 0.22 | 116 | 0.10 | 0.93 | cfa05161=Hepatitis B |
43 | 0.23 | 113 | 0.095 | 0.93 | cfa04144=Endocytosis |
14 | 0.20 | 128 | 0.11 | 0.94 | cfa05220=Chronic myeloid leukemia |
5 | 0.17 | 146 | 0.15 | 0.94 | cfa04744=Phototransduction |
6 | 0.18 | 142 | 0.13 | 0.94 | cfa04130=SNARE interactions in vesicular transport |
12 | 0.19 | 133 | 0.079 | 0.96 | cfa05211=Renal cell carcinoma |
23 | 0.21 | 125 | 0.067 | 0.96 | cfa05162=Measles |
4 | 0.15 | 154 | 0.11 | 0.96 | cfa03020=RNA polymerase |
10 | 0.18 | 141 | 0.063 | 0.97 | cfa00562=Inositol phosphate metabolism |
4 | 0.14 | 161 | 0.079 | 0.97 | cfa04710=Circadian rhythm |
10 | 0.17 | 146 | 0.047 | 0.98 | cfa05210=Colorectal cancer |
15 | 0.18 | 139 | 0.034 | 0.98 | cfa04914=Progesterone-mediated oocyte maturation |
20 | 0.19 | 133 | 0.028 | 0.98 | cfa04270=Vascular smooth muscle contraction |
40 | 0.21 | 123 | 0.032 | 0.98 | cfa04510=Focal adhesion |
8 | 0.16 | 150 | 0.048 | 0.98 | cfa05213=Endometrial cancer |
10 | 0.15 | 154 | 0.015 | 0.99 | cfa05212=Pancreatic cancer |
10 | 0.16 | 149 | 0.029 | 0.99 | cfa04260=Cardiac muscle contraction |
10 | 0.16 | 153 | 0.021 | 0.99 | cfa05214=Glioma |
13 | 0.16 | 151 | 0.012 | 0.99 | cfa05215=Prostate cancer |
14 | 0.17 | 148 | 0.016 | 0.99 | cfa04012=ErbB signaling pathway |
14 | 0.18 | 144 | 0.025 | 0.99 | cfa04620=Toll-like receptor signaling pathway |
15 | 0.17 | 146 | 0.017 | 0.99 | cfa04650=Natural killer cell mediated cytotoxicity |
17 | 0.18 | 143 | 0.014 | 0.99 | cfa04114=Oocyte meiosis |
24 | 0.18 | 137 | 0.010 | 0.99 | cfa04910=Insulin signaling pathway |
32 | 0.20 | 130 | 0.015 | 0.99 | cfa05010=Alzheimer's disease |
33 | 0.20 | 131 | 0.010 | 0.99 | cfa05016=Huntington's disease |
8 | 0.15 | 158 | 0.020 | 0.99 | cfa04730=Long-term depression |
9 | 0.15 | 157 | 0.016 | 0.99 | cfa03018=RNA degradation |
9 | 0.15 | 157 | 0.016 | 0.99 | cfa04664=Fc epsilon RI signaling pathway |
0 | 0.0 | 204 | 0.38 | 1.0 | cfa00471=D-Glutamine and D-glutamate metabolism |
1 | 0.036 | 201 | 0.0014 | 1.0 | cfa00020=Citrate cycle (TCA cycle) |
1 | 0.045 | 198 | 0.0076 | 1.0 | cfa03060=Protein export |
1 | 0.053 | 196 | 0.018 | 1.0 | cfa04964=Proximal tubule bicarbonate reclamation |
1 | 0.059 | 194 | 0.030 | 1.0 | cfa00532=Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate |
10 | 0.13 | 171 | 0.0017 | 1.0 | cfa04912=GnRH signaling pathway |
10 | 0.13 | 172 | 0.0014 | 1.0 | cfa04070=Phosphatidylinositol signaling system |
10 | 0.14 | 163 | 0.0053 | 1.0 | cfa05100=Bacterial invasion of epithelial cells |
11 | 0.087 | 186 | 1.6E-7 | 1.0 | cfa04310=Wnt signaling pathway |
11 | 0.13 | 170 | 0.0012 | 1.0 | cfa04666=Fc gamma R-mediated phagocytosis |
11 | 0.15 | 156 | 0.0087 | 1.0 | cfa04970=Salivary secretion |
13 | 0.083 | 187 | 1.9E-9 | 1.0 | cfa05034=Alcoholism |
13 | 0.13 | 167 | 0.00067 | 1.0 | cfa04660=T cell receptor signaling pathway |
15 | 0.12 | 173 | 0.000058 | 1.0 | cfa04360=Axon guidance |
15 | 0.12 | 173 | 0.000058 | 1.0 | cfa04530=Tight junction |
15 | 0.12 | 175 | 0.000010 | 1.0 | cfa04390=Hippo signaling pathway |
15 | 0.14 | 164 | 0.00065 | 1.0 | cfa04722=Neurotrophin signaling pathway |
18 | 0.13 | 169 | 0.000042 | 1.0 | cfa03010=Ribosome |
18 | 0.14 | 165 | 0.00015 | 1.0 | cfa04120=Ubiquitin mediated proteolysis |
18 | 0.16 | 152 | 0.0035 | 1.0 | cfa05322=Systemic lupus erythematosus |
2 | 0.016 | 203 | 8.1E-15 | 1.0 | cfa03040=Spliceosome |
2 | 0.028 | 202 | 3.3E-8 | 1.0 | cfa03015=mRNA surveillance pathway |
26 | 0.19 | 135 | 0.0088 | 1.0 | cfa03013=RNA transport |
27 | 0.15 | 159 | 0.000019 | 1.0 | cfa05203=Viral carcinogenesis |
28 | 0.17 | 145 | 0.0018 | 1.0 | cfa04141=Protein processing in endoplasmic reticulum |
28 | 0.17 | 148 | 0.00087 | 1.0 | cfa04062=Chemokine signaling pathway |
29 | 0.17 | 147 | 0.00094 | 1.0 | cfa05169=Epstein-Barr virus infection |
3 | 0.038 | 200 | 5.6E-8 | 1.0 | cfa04727=GABAergic synapse |
3 | 0.052 | 197 | 0.000014 | 1.0 | cfa04720=Long-term potentiation |
3 | 0.067 | 189 | 0.00045 | 1.0 | cfa04961=Endocrine and other factor-regulated calcium reabsorption |
3 | 0.070 | 188 | 0.00076 | 1.0 | cfa04962=Vasopressin-regulated water reabsorption |
3 | 0.091 | 184 | 0.0090 | 1.0 | cfa05033=Nicotine addiction |
30 | 0.15 | 155 | 0.000038 | 1.0 | cfa04810=Regulation of actin cytoskeleton |
31 | 0.18 | 138 | 0.0040 | 1.0 | cfa04020=Calcium signaling pathway |
34 | 0.14 | 160 | 0.0000011 | 1.0 | cfa04010=MAPK signaling pathway |
4 | 0.061 | 192 | 0.000010 | 1.0 | cfa04971=Gastric acid secretion |
4 | 0.098 | 182 | 0.0050 | 1.0 | cfa03022=Basal transcription factors |
46 | 0.19 | 132 | 0.0017 | 1.0 | cfa05166=HTLV-I infection |
5 | 0.043 | 199 | 6.9E-11 | 1.0 | cfa04728=Dopaminergic synapse |
5 | 0.056 | 195 | 1.4E-7 | 1.0 | cfa04723=Retrograde endocannabinoid signaling |
5 | 0.062 | 190 | 0.0000011 | 1.0 | cfa04540=Gap junction |
5 | 0.11 | 177 | 0.0082 | 1.0 | cfa05030=Cocaine addiction |
5 | 0.11 | 180 | 0.0066 | 1.0 | cfa03050=Proteasome |
5 | 0.12 | 175 | 0.010 | 1.0 | cfa04340=Hedgehog signaling pathway |
6 | 0.059 | 193 | 3.4E-8 | 1.0 | cfa04725=Cholinergic synapse |
6 | 0.061 | 191 | 7.4E-8 | 1.0 | cfa04724=Glutamatergic synapse |
6 | 0.10 | 181 | 0.0012 | 1.0 | cfa05031=Amphetamine addiction |
6 | 0.12 | 174 | 0.0084 | 1.0 | cfa05217=Basal cell carcinoma |
6 | 0.12 | 176 | 0.0045 | 1.0 | cfa05223=Non-small cell lung cancer |
62 | 0.21 | 126 | 0.0038 | 1.0 | cfa05200=Pathways in cancer |
66 | 0.14 | 162 | 1.1E-11 | 1.0 | cfa04740=Olfactory transduction |
7 | 0.11 | 178 | 0.0016 | 1.0 | cfa04520=Adherens junction |
7 | 0.13 | 166 | 0.012 | 1.0 | cfa05221=Acute myeloid leukemia |
8 | 0.090 | 185 | 0.000014 | 1.0 | cfa04713=Circadian entrainment |
8 | 0.090 | 185 | 0.000014 | 1.0 | cfa04916=Melanogenesis |
8 | 0.095 | 183 | 0.000044 | 1.0 | cfa05032=Morphine addiction |
8 | 0.11 | 179 | 0.00075 | 1.0 | cfa05132=Salmonella infection |
8 | 0.13 | 168 | 0.0068 | 1.0 | cfa04150=mTOR signaling pathway |
8 | 0.13 | 168 | 0.0068 | 1.0 | cfa04721=Synaptic vesicle cycle |
9 | 0.14 | 161 | 0.0095 | 1.0 | cfa04662=B cell receptor signaling pathway |
32 | 0.68 | 7 | 1.0 | 1.2E-8 | cfa03460=Fanconi anemia pathway |
34 | 0.64 | 9 | 1.0 | 4.2E-8 | cfa00590=Arachidonic acid metabolism |
85 | 0.45 | 40 | 1.0 | 4.9E-7 | cfa04060=Cytokine-cytokine receptor interaction |
34 | 0.60 | 12 | 1.0 | 5.3E-7 | cfa04610=Complement and coagulation cascades |
408 | 0.38 | 60 | 1.0 | 8.6E-11 | cfa01100=Metabolic pathways |
|